A rapid multidisciplinary approach is needed to reduce serum free light chain levels and restore kidney function ...

Sodium-glucose co-transporter 2 (SGLT2) inhibitors, initially developed to treat type 2 diabetes, have significant heart- and ...

When the kidneys are damaged—after surgery, cardiac arrest, or as a side effect of certain medications—doctors often face one ...

Sodium-glucose co-transporter 2 (SGLT2) inhibitors, initially developed to treat type 2 diabetes, have significant heart- and ...

Researchers from Aarhus University have discovered a protein that can predict whether kidney cells will survive or die after acute injury. The finding could pave the way for new treatments and benefit ...

The Korea Institute of Ocean Science and Technology (KIOST), led by President Lee Heeseung, in collaboration with Professor ...

A research team has developed pioneering technology that enables human kidney organoids to be produced on a scalable basis. These organoids can then be combined with pig kidneys outside the body and ...

Sodium-glucose co-transporter 2 (SGLT2) inhibitors, initially developed to treat type 2 diabetes, have significant heart- and kidney- protective ...

The remarkable journey of an erythrocyte, or red blood cell, from the renal artery is a testament to the intricate and efficient design of the human circulatory and renal systems. Imagine yourself as ...

Other risk factors for kidney disease include chronic infections, autoimmune disorders, and certain genetic variants. The new ...

In FSGS, podocytes are damaged, like a net with torn holes, allowing protein to leak into the urine, creating a harmful ...

Finerenone shows significant benefits in patients with kidney disease and type 1 diabetes, which could lead to the first ...